Author:
Imamura Teruhiko,Kinugawa Koichiro,Nitta Daisuke,Fujino Takeo,Inaba Toshiro,Maki Hisataka,Hatano Masaru,Kinoshita Osamu,Nawata Kan,Kyo Shunei,Ono Minoru
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Biomedical Engineering,Biomaterials,Medicine (miscellaneous)
Reference20 articles.
1. Floras JS. Sympathetic activation in human heart failure: diverse mechanisms, therapeutic opportunities. Acta Physiol Scand. 2003;177:391–8.
2. Metra M, Nodari S, D’Aloia A, Bontempi L, Boldi E, Cas LD. A rationale for the use of beta-blockers as standard treatment for heart failure. Am Heart J. 2000;139:511–21.
3. The Cardiac Insufficiency Bisoprolol Study II. (CIBIS-II): a randomised trial. Lancet. 1999;353:9–13.
4. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334:1349–55.
5. George RS, Birks EJ, Cheetham A, Webb C, Smolenski RT, Khaghani A, Yacoub MH, Kelion A. The effect of long-term left ventricular assist device support on myocardial sympathetic activity in patients with non-ischaemic dilated cardiomyopathy. Eur J Heart Fail. 2013;15:1035–43.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献